HPOB
- Product Name
- HPOB
- CAS No.
- 1429651-50-2
- Chemical Name
- HPOB
- Synonyms
- HPOB;CS-1829;HPOB, 10 mM in DMSO;HPOB,HDAC6 inhibitor;N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide;4-[(Hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenyl-benzeneacetamide;Benzeneacetamide, 4-[(hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenyl-;4-[(hydroxyamino)carbonyl]-N-(2-hydroxyethyl)-N-phenyl- benzeneacetamide HPOB
- CBNumber
- CB82730376
- Molecular Formula
- C17H18N2O4
- Formula Weight
- 314.34
- MOL File
- 1429651-50-2.mol
HPOB Property
- storage temp.
- 2-8°C
- solubility
- DMSO: soluble1mg/mL, clear (warmed)
- form
- powder
- color
- white to beige
- InChI
- InChI=1S/C17H18N2O4/c20-11-10-19(15-4-2-1-3-5-15)16(21)12-13-6-8-14(9-7-13)17(22)18-23/h1-9,20,23H,10-12H2,(H,18,22)
- InChIKey
- RFAZNTABYJYOAR-UHFFFAOYSA-N
- SMILES
- C1(CC(N(CCO)C2=CC=CC=C2)=O)=CC=C(C(NO)=O)C=C1
Safety
- WGK Germany
- 3
N-Bromosuccinimide Price
- Product number
- SML0906
- Product name
- HPOB
- Purity
- ≥98% (HPLC)
- Packaging
- 5mg
- Price
- $115.9
- Updated
- 2025/07/31
- Product number
- SML0906
- Product name
- HPOB
- Purity
- ≥98% (HPLC)
- Packaging
- 25mg
- Price
- $477
- Updated
- 2022/05/15
- Product number
- 15066
- Product name
- HPOB
- Purity
- ≥95%
- Packaging
- 1mg
- Price
- $32
- Updated
- 2024/03/01
- Product number
- 15066
- Product name
- HPOB
- Purity
- ≥95%
- Packaging
- 5mg
- Price
- $100
- Updated
- 2024/03/01
- Product number
- 15066
- Product name
- HPOB
- Purity
- ≥95%
- Packaging
- 10mg
- Price
- $184
- Updated
- 2024/03/01
HPOB Chemical Properties,Usage,Production
Uses
HPOB is a histone deacetylase 6 inhibitor used in the enhancement of anti-cancer drugs.
Biological Activity
HPOB is a very potent, selective inhibitor of HDAC6. HPOB inhibits proliferation of normal and transformed cell lines but does not induce cell death. The compound HPOB potentiates the effects of DNA-damaging cytotoxic anti-cancer drugs.
Synthesis
1429653-16-6
1429651-50-2
4-(2-((((tert-butyldimethylsilyl)oxy)ethyl)(phenyl)amino)-2-oxoethyl)-N-hydroxybenzamide (16 mg, 0.037 mmol) was used as a starting material, which was dissolved in a solution (3 mL) of dichloromethane (CH2Cl2) containing 5% trifluoroacetic acid (TFA) and the reaction was stirred for 5 minutes. After completion of the reaction, the organic phase was concentrated under reduced pressure. The crude product was purified by silica gel column chromatography with the eluent dichloromethane/methanol (10:1, v/v) to afford the target compound N-hydroxy-4-(2-((2-hydroxyethyl)(phenyl)amino)-2-oxoethyl)benzamide in a yield of 8 mg and 68%. Thin layer chromatography (TLC) Rf value was 0.23 (unfolding agent: dichloromethane/methanol, 10:1). Nuclear magnetic resonance hydrogen spectrum (1H NMR, CD3OD, 400 MHz): δ 7.64 (d, J = 8.4 Hz, 2H), 7.45 (m, 3H), 7.29 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 3.86 (t, J = 6.0 Hz, 2H), 3.68 (t, J = 6.0 Hz. 2H), 3.55 (s, 2H). NMR carbon spectrum (13C NMR, CD3OD, 100 MHz): δ 172.0, 166.9, 142.7, 139.7, 130.9, 129.9, 129.4, 128.7, 128.5, 127.1, 58.8, 51.8, 41.0. mass spectra (APCI+): [M + H]+ m/z = 315.26 .
in vivo
HPOB (300 mg/kg; i.p.; daily for 18 days) and SAHA (50 mg/kg) causes suppression of the growth of established CWR22 tumors[1].
| Animal Model: | Nude mice (CWR22 human prostate cancer xenograf)[1] |
| Dosage: | 300 mg/kg |
| Administration: | I.p.; daily for 18 days |
| Result: | Combination with SAHA showed significant shrinkage of CWR22 tumors. |
IC 50
HDAC6: 0.056 μM (IC50); HDAC3/NCOR2: 1.7 μM (IC50); HDAC8: 2.8 μM (IC50); HDAC1: 2.9 μM (IC50); HDAC10: 3.0 μM (IC50); HDAC2: 4.4 μM (IC50)
References
[1] Patent: WO2013/52110, 2013, A1. Location in patent: Page/Page column 46; 48
HPOB Preparation Products And Raw materials
Raw materials
Preparation Products
HPOB Suppliers
- Tel
- 17317130613
- Fax
- QQ3358272972
- 3358272972@qq.com
- Country
- China
- ProdList
- 3276
- Advantage
- 58
- Tel
- 0411-62910999 13889544652
- sales@meilune.com
- Country
- China
- ProdList
- 4747
- Advantage
- 58
- Tel
- 021-58955995
- Fax
- 609-228-5909
- sales@medchemexpress.cn
- Country
- United States
- ProdList
- 4861
- Advantage
- 58
- Tel
- +1 (866) 930-6790
- Fax
- +1 (866) 333-9607
- info@adooq.com
- Country
- United States
- ProdList
- 2782
- Advantage
- 58
- Tel
- 025-58849295 18951903616;
- Fax
- 025-68650336
- info@adooq.cn
- Country
- China
- ProdList
- 2990
- Advantage
- 60
- Tel
- 021-52996696,15000506266 15000506266
- Fax
- +86-21-52996696
- Country
- China
- ProdList
- 4757
- Advantage
- 55
- Tel
- 16314854226
- info@bocsci.com
- Country
- United States
- ProdList
- 9923
- Advantage
- 65
- Tel
- +86-400-851-9921
- Fax
- +86-10-82826195
- sales@pharmacodia.com
- Country
- China
- ProdList
- 2317
- Advantage
- 55
- Tel
- 021-65675885 18964387627
- Fax
- 021-65675885
- info@efebio.com
- Country
- China
- ProdList
- 9803
- Advantage
- 58
- Tel
- 021-61312847; 18021002903
- Fax
- QQ:3008007432
- 3008007409@qq.com
- Country
- China
- ProdList
- 71826
- Advantage
- 60